(Q38051068)

27 August 2017

title

Meeting the biologic challenge of colorectal metastases (English)

1 reference

27 August 2017

Harold J Wanebo

1

1 reference

27 August 2017

Mark LeGolvan

2

1 reference

27 August 2017

Philip B Paty

3

1 reference

27 August 2017

Sukamal Saha

4

1 reference

27 August 2017

Markus Zuber

5

1 reference

27 August 2017

Michael I D'Angelica

6

1 reference

27 August 2017

Nancey E Kemeny

7

1 reference

27 August 2017

language of work or name

1 reference

10 October 2012

1 reference

Clinical & Experimental Metastasis

27 August 2017

published in

1 reference

27 August 2017

volume

29

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

821-839

1 reference

https://scigraph.springernature.com/pub.10.1007/s10585-012-9517-x

27 August 2017

exact match

0 references

cites work

Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

VEGF receptor signalling - in control of vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Expression profiling of epithelial plasticity in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Laminin-5 in the progression of carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Defining the role of laminin-332 in carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

The engagement of selectins and their ligands in colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Prognostic significance of beta-catenin in colorectal cancer with liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Integrins: a method of early intervention in the treatment of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Role of matrix metalloproteinases (MMPs) in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Molecular mechanisms of hepatic metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Amphiregulin is a promising prognostic marker for liver metastases of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

The VEGF family in cancer and antibody-based strategies for their inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

The role of the Angiopoietins in vascular morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

p53 mutations in matched primary and metastatic human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Structural, functional and therapeutic biology of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

One step nucleic acid amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Molecular investigation of lymph nodes in colon cancer patients using one-step nucleic acid amplification (OSNA): a new road to better staging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Treatment of liver colorectal metastases: role of laparoscopy, radiofrequency ablation, and microwave coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Hepatic resection for metastases from colorectal carcinoma is of dubious value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Actual 10-year survival after resection of colorectal liver metastases defines cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Personalized colon cancer care in 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Determinants of survival in liver resection for colorectal secondaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Tumor and liver drug uptake following hepatic artery and portal vein infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Intrahepatic arterial infusion of chemotherapy: pharmacologic principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Pharmacologic rationale for regional drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

The role of floxuridine in metastatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

A new look at the arterial supply of the bile duct in man and its surgical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Role of adjuvant therapy after resection of colorectal cancer liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Hepatic arterial infusion after liver resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Increased Use of Parenchymal-Sparing Surgery for Bilateral Liver Metastases From Colorectal Cancer Is Associated With Improved Mortality Without Change in Oncologic Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

The impact of margins on outcome after hepatic resection for colorectal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-012-9517-X

Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases

21 January 2018

1 reference

12 December 2020

Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect

1 reference

12 December 2020

Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution

1 reference

12 December 2020

The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth

1 reference

12 December 2020

Clinical pharmacology of hepatic arterial chemotherapy

1 reference

12 December 2020

Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator

1 reference

12 December 2020

Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer

1 reference

12 December 2020

Totally implanted drug delivery system for hepatic arterial chemotherapy

1 reference

12 December 2020

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

12 December 2020

OSNA-based novel molecular testing for lymph node metastases in colorectal cancer patients: results from a multicenter clinical performance study in Japan

1 reference

12 December 2020

Liver metastases from colorectal cancer: the turning point

1 reference

12 December 2020

Pharmacologic rationale for hepatic arterial therapy.

1 reference

12 December 2020

Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.

1 reference

12 December 2020

One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients

1 reference

12 December 2020

Clinical, biological, and molecular aspects of metastasis in colorectal cancer.

1 reference

12 December 2020

Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study

1 reference

12 December 2020

Prognostic significance of expression of matrix metalloproteinase in colorectal adenocarcinomas and their metastases

1 reference

12 December 2020

Expression and prognostic significance of angiopoietin in colorectal carcinoma

1 reference

12 December 2020

Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment

1 reference

12 December 2020

Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis

1 reference

12 December 2020

The status of p53 in the metastatic progression of colorectal cancer

1 reference

12 December 2020

Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases

1 reference

12 December 2020

Expression of vascular endothelial growth factor and thrombospondin-1 in colorectal carcinoma

1 reference

12 December 2020

Continuous administration of irinotecan by hepatic arterial infusion: a phase I and pharmacokinetic study.

1 reference

12 December 2020

1 reference

12 December 2020

The blood supply of neoplasms in the liver

1 reference

12 December 2020

Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.

1 reference

12 December 2020

Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.

1 reference

12 December 2020

P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression

1 reference

12 December 2020

Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.

1 reference

12 December 2020

Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma

1 reference

12 December 2020

Key enzymes of the extracellular matrix in colorectal cancer

1 reference

12 December 2020

The treatment of metastatic carcinoma of the liver by the percutaneous selective hepatic artery infusion of 5-fluorouracil

1 reference

12 December 2020

Debunking dogma: surgery for four or more colorectal liver metastases is justified

1 reference

12 December 2020

Metastasis mechanisms

1 reference

12 December 2020

Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal

1 reference

12 December 2020

Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells

1 reference

12 December 2020

Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology

1 reference

12 December 2020

Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?

1 reference

12 December 2020

Expression of E-cadherin, beta-catenin, and CD-44v6 cell adhesion molecules in primary tumors and metastases of colorectal adenocarcinoma

1 reference

12 December 2020

10.1007/S10585-012-9517-X

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1037274733

0 references

1 reference